BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- Korea’s biotechnology sector is at a strategic ...

BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- More than 80 Korean pharmaceutical, biotech, and ...

The Ministry of Food and Drug Safety (MFDS) said it granted orphan drug and developmental orphan drug designations to two ...

Korean physicians recently pointed out that, to institutionalize the limited-time permitted telemedicine care, platforms ...

BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- Huonslab, a subsidiary of Huons Group, said it presented its formulation conversion technology using human hyaluronidase at t ...

D&D Pharmatech said Monday that its GLP-1/glucagon dual agonist DD01 met the primary endpoint in a U.S. phase 2 study in ...

A 16-month-long government-doctor conflict is unable to find a way out. The hope that a change in political power will soon ...

Samsung Bioepis and its European partner Biogen have been dealt a legal blow in Germany after a higher court ruled that ...

Just because you can't hear doesn't mean you can't sing.Big Ocean, the world's first deaf idol group, is proof of this.

Patients with urothelial carcinoma are increasingly abandoning treatment. New drugs are being developed, but health insurance ...

Yuhan Corp. is making an early case for its allergy biologic YH35324 in chronic spontaneous urticaria (CSU), the medical term ...

A mobile game-based digital therapy has been shown to help improve social skills in adolescents with autism spectrum disorder ...